Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · NJ, CA · May 6, 2019 → Aug 1, 2024
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:06 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Benjamin Cravatt is listed as a director on 5 SEC Form D filings by 2 issuers between Apr 2016 and Aug 2024: Vividion Therapeutics, Inc. (San Diego, CA — biotechnology — 2016–2021; $135M reported sold to 27 investors) and Autobahn Therapeutics, Inc. (San Diego, CA — biotechnology — 2024; $100.8M reported sold to 22 investors).
What this means 2 separate companies raised money with this person listed as director, over about 8 years. Across those companies the filings report $235.8M sold in total.
Listed alongside John K. Clarke (4 shared filings), Kristina Burow (3 shared filings), Jakob Loven (2 shared filings), John Park (2 shared filings), Richard Heyman (2 shared filings) and 15 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Benjamin. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Benjamin Cravatt and found 12 differences: Bankruptcy case: MBNA America Bank v. Miralles; Bankruptcy case: Diamond v. Miralles Associates, Inc; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Benjamin Cravatt has not run yet — it is joining a line of 20,591 names; searches run around the clock at the hosts' allowed rate. Searched so far: 313 names.
Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:06 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: NV (crawled Oct 23, 2026)
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Benjamin Cravatt..
State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for IA, IN, KS, MI, NE, NV (see docs/state-regulators.md).
None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:06 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
12 differences found between the filings for Benjamin Cravatt (compared 5 filings on Oct 24, 2026)
United States Bankruptcy Court, E.D. California docket "MBNA America Bank v. Miralles" filed Dec 18, 2001, closed Mar 1, 2002. Diego K. Miralles (listed on the same filings) is listed as Defendant ("Miralles"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
United States Bankruptcy Court, C.D. California docket "Diamond v. Miralles Associates, Inc" filed Sep 17, 1997, closed May 1, 1998. Diego K. Miralles (listed on the same filings) is listed as Defendant ("Miralles Associates, Inc"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The filing says the first sale was Jun 20, 2024. The Form D was filed Aug 1, 2024 — 42 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 27 days past that.
What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.
The latest filing for this offering is dated Aug 1, 2024 (first sale Jun 20, 2024). It reports $100,825,289 sold of $120,000,000 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
The latest filing for this offering is dated Jan 18, 2017 (first sale Jan 3, 2017). It reports $20,200,000 sold of $50,500,000 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
The latest filing for this offering is dated Apr 11, 2016 (first sale Mar 31, 2016). It reports $3,504,616 sold of $4,000,000 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
"No Revenues" (Apr 11, 2016); then "Decline to Disclose" (Jan 18, 2017).
What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.
This page covers filings where the address state is NJ or CA. A separate record, "Benjamin F. Cravatt" with address state MA, is listed on 3 filings — most recently by Sea Pharmaceuticals, LLC (Oct 11, 2023). Both records have filings in the same period (May 6, 2019 to Oct 11, 2023).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is NJ or CA. A separate record, "Benjamin J. Cravatt" with address state MA, is listed on 4 filings — most recently by Sea Pharmaceuticals, LLC (Jan 14, 2022). Both records have filings in the same period (May 6, 2019 to Jan 14, 2022).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is NJ or CA. A separate record, "Benjamin Cravatt" with address state MA, is listed on 1 filing — most recently by Sea Pharmaceuticals, LLC (Nov 16, 2016). The two records do not overlap in time: this page runs May 6, 2019 to Aug 1, 2024; the other has one filing dated Nov 16, 2016.
What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Jan 18, 2017 filing give Princeton, NJ; on the May 6, 2019 filing they give San Diego, CA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
NJ on 2 filings (Apr 11, 2016 to Jan 18, 2017); CA on 3 filings (May 6, 2019 to Aug 1, 2024).
What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
None reported on 5 offerings — no sales commissions, finder's fees or proceeds to insiders
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Aug 1, 2024 D Autobahn Therapeutics, Inc. File 021-520406 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 2, 2021 D Vividion Therapeutics, Inc. File 021-390895 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 6, 2019 D Vividion Therapeutics, Inc. File 021-338900 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 18, 2017 D Vividion Therapeutics, Inc. File 021-278715 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 11, 2016 D Vividion Therapeutics, Inc. File 021-261009 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Benjamin Cravatt on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $100.8M from 22 investors (84% of the $120M target) as of the latest filing. Benjamin is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $135M from 27 investors (100% of the $135M target) as of the latest filing. Benjamin is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.
John K. Clarke is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Kristina Burow is on 32 issuers in total — a repeat sponsor. Their page lists every one.
Richard Heyman is on 8 issuers in total — a repeat sponsor. Their page lists every one.
Thomas Woiwode is on 25 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Patricia L. Allen is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
Listed on the same filings as Benjamin Cravatt. Their page shows their other deals.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Benjamin Cravatt by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Benjamin Cravatt is listed on: none on file. No website or social profile named in Autobahn Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #93,870 of 374,652 in line (481 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Benjamin Cravatt appears on a new Form D, or when a court case or SEC action is matched to them. See plans →